Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07469462Completed
Randomised trial in major depressive disorder (MDD) and anxiety disorder (2 arms), sponsored by University of Reading. Primary endpoint: Neural inhibition measured using Electroencephalography at 1 week. Started Mar 2026; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07469462.